MENU
Entrada Therapeutics (TRDA) Ownership - Who owns Entrada Therapeutics?
Profile
Industry
N/A
Address
One Design Center Place
Phone
+1 857 520-9158
Employees
159
Web
https://www.entradatx.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
572.5M
P/E Ratio
5.10
Total Cash
469.75M
Projected Growth
N/A
Total Debt
64.44M
Revenue
239.4M
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash/Share
12.63
Total Debt/Equity
N/A
Revenue/Share
6.99 USD as % of share price
Fundamentals
TRDA
Capitalization
573M
P/E Ratio
5.10
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash
470M
Total Cash/Share
12.63
Total Debt
64.4M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
6.99%
Revenue
239M
ROE
N/A
Book Value
430M
P/B Ratio
1.33
Cash Flow
N/A
Earnings
3.11
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
4K
Current Ratio
5.70
Current Revenue Per Employee
563654.75
Dividends Per Share - Security
N/A
EBITDA
96.9M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
19.41
Shares Held By Institutions
511M
Shares Outstanding - Current
37.2M
Total Liabilities
152M
Total Volume MTD
N/A
Value
N/A
Gain YTD
1.988
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
One Design Center Place
Phone
+1 857 520-9158
Employees
159
Web
https://www.entradatx.com